Clinical Trial Update: Effect of SHR8058 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating SHR8058 for signs and symptoms of dry eye disease associated with Meibomian gland dysfunction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Meibomian Gland Dysfunction

Drugs mentioned

• SHR8058

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Treatment of Dry Eye Disease With Meibomian Gland Dysfunction | Phase 3 | Status: COMPLETED